Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernewsroom.regeneron.com
Regeneron Pharmaceuticals Inc. News Releases
Get the latest updates from Regeneron Pharmaceuticals Inc. News Releases directly as they happen.
Follow now 148 followers
Latest posts
Last updated 6 days ago
Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment
6 days ago
If approved, Dupixent would be the first targeted medicine in the EU...
Regeneron Renews Sponsorship of the Regeneron Science Talent Search Through 2036, Committing an Additional $150 Million to Empower the Next Generation of Science and Technology Leaders
7 days ago
Key Takeaways: Regeneron will extend its title sponsorship of the Regeneron Science...
Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)
9 days ago
Approval in adults and children aged 6 years and older supported by...
Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
14 days ago
FOP is an ultra-rare genetic disorder characterized by abnormal bone formation that...
Regeneron Announces Investor Conference Presentations
21 days ago
TARRYTOWN, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ...
Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy
23 days ago
36 abstracts to be presented across Regeneron -invented therapies, including first-time Phase...
EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases
about 1 month ago
New presentations include final 64-week results from the Phase 3 QUASAR trial...
Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
about 1 month ago
Fourth quarter 2025 revenues increased 3% to $3.9 billion versus fourth quarter...
Nation’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at the Prestigious Regeneron Science Talent Search
about 1 month ago
The Regeneron Science Talent Search Honors America’s Brightest Young Scientists Advancing Discovery...
Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026
2 months ago
TARRYTOWN, N.Y. , Jan. 02, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
2 months ago
Approval based on global Phase 3 program in children demonstrating Dupixent significantly...
Regeneron Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
2 months ago
TARRYTOWN, N.Y. , Dec. 22, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...